United States · Venture startup

Who invested in Diasome Pharmaceuticals

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$9.0Mraised across 1 round since 2023, from 1 source

Latest round
Venture, $9.0MJun 2023
Investors
0
See who backed them

The rounds

  1. Jun 2023
    Venture$9.0M

    No investor was named in the report.

    Source recordedSEC filing: $9.0M sold, first sale Jun 2023

Funding filed with regulators

Diasome Pharmaceuticals filed 8 raises, $63M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Jul 2024$3.1M4 investorsof $16M offeredSEC Form D
  2. Jun 2023$9.0M2 investorsequityof $15M offeredSEC Form D
  3. Aug 2022$17M40 investorsequityof $19M offeredSEC Form D
  4. Sept 2020$1.5M6 investorsdebt, optionsof $5.0M offeredSEC Form D
  5. Mar 2020$2.9M20 investorsequityof $2.9M offeredSEC Form D
  6. Oct 2018$12M22 investorsdebtof $19M offeredSEC Form D
  7. Dec 2016$4.3M4 investorsdebtof $8.0M offeredSEC Form D
  8. Mar 2008$13M9 investorsequity, debtof $13M offeredSEC Form D

Founders and team

From Diasome Pharmaceuticals's own website: 5 on the team.

  • J. Lincoln ChapinVice President of Clinical Operations
  • Linda RubinsteinChief Financial Officer
  • Eric EdidinBoard Chairman
  • Frank McCaneyDirector
  • Thomas McDonaldDirector

Quick answers about Diasome Pharmaceuticals

How much has Diasome Pharmaceuticals raised?

Diasome Pharmaceuticals has raised $9.0M across 1 round since 2023.

When did Diasome Pharmaceuticals last raise?

Diasome Pharmaceuticals's most recent round was a Venture of $9.0M in Jun 2023.

What was Diasome Pharmaceuticals's biggest round?

Its most recent round, $9.0M in Jun 2023, is also its largest on record.

What stage is Diasome Pharmaceuticals at?

Diasome Pharmaceuticals's latest named round is a Venture, in Jun 2023.

Where is Diasome Pharmaceuticals based?

Diasome Pharmaceuticals is based in the United States.

Companies like Diasome Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Neuvivo$1.4M · Nov 2026Mirendil$1.4B · Nov 2026Nanopath$25M · Nov 2026InSitu Biologics$22M · Nov 2026Frontier Bio$1.7M · Nov 2026CARI Health$3.1M · Nov 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app